Anxiety and anxiety disorders in cardiology practice
Abstract
The review contains data on prevalence, clinics and clinical value of anxiety disorders (AD) in cardiology practice. Differential diagnostics of pathological anxiety somatic symptoms and cardiovascular disease symptoms are reviewed. AD screening principles in cardiac patients are described. Clinical trials’ results on AD input in coronary heart disease and arterial hypertension pathogenesis, as well as on cardiovascular death risk increase in patients with pathological anxiety, are analyzed. Potential pathogenetic mechanisms explaining this link are discussed. Finally, practical recommendations on AD treatment in cardiac patients are delivered, according to international consensus on anxiety in cardiology.
About the Author
E. G. Starostina
M.F. Vladimirsky Moscow Region Research Clinical Institute. Moscow
Russian Federation
Russian Federation
References
1. Бобров А.Е., Белянчикова М.А. Распространенность и структура психических расстройств в семьях женщин, страдающих пороками сердца (лонгитудинальное исследование). Ж невропатол психиат 1999; 99: 52-5.
2. Оганов РГ, Ольбинская ЛИ, Смулевич АБ. и др. Депрессия в общемедицинской практике. Результаты программы КОМПАС. Кардиология 2004; 1: 48-54.
3. Смулевич А.Б, Сыркин А.Л., Дробижев М.Ю. и др. Терапия кардионевротических расстройств в общетерапевтической практике: опыт применения атаракса. Клин мед 1999; 1: 43-6.
4. Старостина Е.Г. Генерализованное тревожное расстройство и симптомы тревоги в общемедицинской практике. РМЖ 2004; 12(22): 1277- 83.
5. Старостина Е.Г. Ожирение как психосоматическое заболевание. Ожир метабол 2005; 3: 18-23.
6. Чуркин А.А., Мартюшов А.Н. Краткое руководство по использованию МКБ-10 в психиатрии и наркологии. Москва «Триада-Х» 1999.
7. Ahern DK, Gorkin L, Anderson JL, et al. for the CAPS Investigators. Biobehavioural variables and mortality or cardiac arrest in the Cardiac Arrhythmias Pilot Study (CAPS). Am J Cardiol 1990; 66: 59-62.
8. Albert CM, Chae CU. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480-7.
9. Allgulander C, Lavori PW. Excess mortality among 3302 patients with «pure» anxiety neurosis. Arch Gen Psychiatry 1991; 48: 599-692.
10. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on depression, anxiety and cardiovascular disease. J Clin Psychiatry 2001; 62: 24-47.
11. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus group on depression and anxiety. J Clin Psychiatry 2001; 62 (Suppl. 11): 53-8.
12. Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med 2004;66(5): 645-50.
13. Barger SD, Sydeman SJ. Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? J Affect Disord 2005; 88(1): 87-91.
14. Benninghoven D, Kaduk A, Wigand U, et al. Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function? Psychother Psychosom 2006; 75(1): 56-61.
15. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Reviews 2001; 2: 73-86.
16. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987; 101: 343-62.
17. Cailey WE. Diagnosing the cause of chest pain. Am Fam Physician 2005; 72: 2012-21.
18. Culpepper L. Generalized anxiety disorder in primary care: emerging issues in management and treatment. J Clin Psychiatry 2002; 63 (Suppl. 8): 35-41.
19. Curtis BM, O’Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002; 77: 45-54.
20. Davies SJ, Ghahramani P, Jackson PR, et al. Association of panic disorder and panic attacks with hypertension. Am J Med 1999; 107(4): 310-6.
21. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998; 97: 167-73.
22. Eaker ED, Sullivan EM, Kelly-Hayes M, et al. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Medicine 2005; 67: 692-6.
23. Ehlers A, Mayou R, Sprigings DC, et al. Psychological and perceptual factors associated with arrhythmias and benign palpitations. Psychosom Med 2000; 62: 693-702.
24. Figgit DP, McClelan KJ. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs 2000; 60(4): 925-54.
25. Fleet R, Lesperance R. Myocardial perfusion study of panic attacks in patients with coronary artery disease. Am J Cardiol 2005; 96(8): 1064-8.
26. Fontaine R, Boysvert D. Psychophysiological disorders in anxious patients: hypertension and hypotension. Psychother Psychosom 1982; 38: 165-72.
27. Frasure-Smith N, Lespоrance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 1995; 14: 388-98.
28. Frenkel YM, Kindler S, Melmed RN. Differences in cognitions during chest pain of patients with panic disorder and ischemic heart disease. Depress Anxiety 1996-97; 4(5): 217-22.
29. Friedman BH, Thayer JF, Borkovec TD, et al. Autonomic characteristics of nonclinical panic and blood phobia. Biol Psychiatry 1993; 34: 298-310.
30. Godemann F, Butter C, Lampe F, et al. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004; 27(6): 321-6.
31. Gullette EC, Blumenthal JA, Babyak M, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA 1997; 277: 1521-6.
32. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischemic heart disease. BMJ 1987; 295: 297-9.
33. Hawort JE, Moniz-Cook E, Clark AL, et al. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005; 7(5): 803-8.
34. Hayword C, Taylor CB. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 1992; 142: 376-8.
35. Hаrter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and medical illness. Eur Arch Psychiatry Clin Neurosci 2003; 253: 313-20.
36. Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999; 318: 1460-7.
37. Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics 2003; 44(3): 222-36.
38. Huffman JC, Stern TA. The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med 2003; 25(4): 427-37.
39. Jiang W, Kuchibhatla M, Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004; 110: 3452-6.
40. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch Fam Med 1997; 6: 43-9.
41. Kane FJ Jr, Harper RG, Wittels E. Angina as a symptom of psychiatric illness. South Med J 1988; 81(11): 1412-6.
42. Kane FJ Jr, Wittels E, Harper RG. Chest pain and anxiety disorder. Tex Med 1990; 86(7): 104-10.
43. Kanel R, Kudielka BM. Hypercoagulability in working men and women with high levels of panic-like anxiety. Psychother Psychosom 2004; 73(6): 353-60.
44. Katerndahl D. Panic and plaques: panic disorder and coronary artery disease in patients with chest pain. J Am Board Fam Pract 2004; 17(2): 114-26.
45. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and coronary artery heart disease in men. Circulation 1994; 89: 1995-7.
46. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90(5): 2225-9.
47. Kawachi I, Sparrow D, Vokonas PS, et al. Decreased heart rate variability in men with phobic anxiety (Data from the Normative Aging Study). Am J Cardiol 1995; 75: 882-5.
48. Keogh E, Hamid R, Hamid S, et al. Investigating the effect of anxiety sensitivity, gender and negative interpretative bias on the perception of chest pain. Pain 2004; 111(1-2): 209-17.
49. Kubzansky LD, Kawachi I, Spiro A, et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997; 95: 818-24.
50. Kubzansky LD, Kawachi I, Weiss ST, et al. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological and experimental evidence. Ann Behav Med 1998; 20: 47 58.
51. Lader M, Scotto JC. A multicentre, double blind comparison of hydroxizine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology 1998; 139: 402-6.
52. Lambert EA, Thompson G, Schlaich M, et al. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens 2002; (12): 2445-51.
53. Lane D, Carroll D, Ring C, et al. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63: 221-30.
54. Lane D, Carrol D, Ring C, et al. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol 2002; 7(Pt 1): 11-21.
55. Lane D, Carrol D, Lip G. Anxiety, depression, and prognosis after myocardial infarction. Is there a causal association? JACC 2003; 42: 1808-10.
56. Lavie C, Milani R. Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol 2004; 93: 336-9.
57. Leibing E, Schunemann I. Psychiatric disorder or coronary heart disease? Psychological test data and ICD-10 diagnoses in patients undergoing coronary angiography. Psychother Psychosom Med Psychol 1998; 48(1): 30-6.
58. Linden W, Stossel C, Maurice J. Psychosocial interventions in patients with coronary artery disease: a meta analysis. Arch Intern Med 1996; 156: 745 52.
59. Llorca PM, Spadone C, Sol O, et al. Efficacy and safety of hydroxizine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 2002; 63: 1020-7.
60. Marciniak M, Lage MJ, Landbloom RP, et al. Medical and productivity costs of anxiety disorders: case control study. Depression and Anxiety 2004; 19: 112-20.
61. Massana J, Lopez-Risueno JA. Subtyping of panic disorder patients with bradycardia. Eur Psychiatry 2001; 16(2): 109-14.
62. Mayou R, Gill D, Thompson DR, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212-9.
63. McLaughlin T, Geissler EC, Wan GJ. Comorbidities and associated treatment charges in patients with anxiety disorders. Pharmacotherapy 2003; 23(10): 1251-6.
64. Morris A, Baker B. Prevalence of panic disorder in cardiac outpatients. Can J Psychiatry 1997; 42(2): 185-90.
65. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996; 58: 395-401.
66. Moser DK, Dracup K, McKinley S, et al. An international perspective on gender differences in anxiety early after acute myocardial infarction. Psychosom Med 2003; 65: 511-6.
67. O’Brien JL, Moser DK, Riegel B, et al. Comparison of anxiety assessments between clinicians and patients with acute myocardial infarction in cardiac critical care units. Am J Crit Care 2001; 10(2): 97-103.
68. Paterniti S, Alperovich A, Ducimetiere P, et al. Anxiety, but not depression is associated with elevated blood pressure in a community group of French elderly. Psychosom Med 1999; 61: 77-83.
69. Paterniti S, Zureik M. Sustained anxiety and 4-year progression of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21(1): 136-41.
70. Peters A, Schweiger U, Pellerin L, et al. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004; 28(2): 143-80.
71. Pollack MH, Allgulander C, Bandelow B, et al. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr 2003; 8(Suppl 1):17-30.
72. Pott SG, Bass CM. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a longterm follow-up study. Psychol Med 1995; 25(2): 339-47.
73. Raikkonen K, Matthews KA, Kuller LH. Trajectory of psychological risk and incident hypertension in middle-aged women. Hypertension 2001; 38: 798-802.
74. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-217.
75. Rutledge T, Reis SE, Olson M, et al. History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. JACC 2001; 37(3): 780-5.
76. Simon J, Lecrubier Y, Ustun TB. Somatic symptoms and psychiatric disorder: an international primary care study. Rev Contemp Pharmacotherapy 1996; 7: 279-85.
77. Sloan RP, Shapiro PA, Bagiella E, et al. Cardiac autonomic control buffers blood pressure variability responses to challenge: a psychophysiologic model of coronary artery disease. Psychosom Med 1999; 61: 58-68.
78. Stein MB, Roy-Byrne PP, McQuaid JR, et al. Development of brief diagnostic screen for panic disorder in primary care. Psychosom Med 1999; 61: 359-64.
79. Strik JJ, Denollet J. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. JACC 2003; 42(10): 1801-7.
80. Sullivan GM, Kent JM, Kleber M, et al. Effects of hyperventilation on heart rate and QT variability in panic disorder pre and post-treatment. Psychiatry Res 2004; 125(1): 29-39.
81. Tallis F, Davey GCL, Capuzzo N. The phenomenology of nonpathological worry: a preliminary investigation. In: Davey G, Tallis F, eds. Worrying: perspectives on theory, assessment, and treatment. New York, NY: John Wiley & Sons 1994; 62-89.
82. Tanabe Y, Harada H. 123I-Metaiodobenzylguanidine myocardial scintigraphy in panic disorder. J Nucl Med 2004; 45(8): 1305-8.
83. Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatry 1996; 39(4): 255-66.
84. Virtanen R, Jula A, Salminen JK, et al. Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-tobeat blood pressure variability. Psychosom Med 2003; 65: 751-6.
85. Watkins SS, Grossman P. Anxiety and vagal control of heart rate. Psychosom Med 1998; 60(4): 498-502.
86. Weissman MM, Markowitz JS, Ouelette R, et al. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990; 147: 1504-8.
87. Wells KB, Golding JM, Burnham NA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145(8): 976-81.
88. Wittchen HU, Beesdo K, Bittner A, et al. Depressive episodesevidence for a causal role of primary anxiety disorders? Eur Psychiatry 2003; 18(8): 384-93.
89. Wyszynski A, Schwartz M, Rubenstein B, et al. The patient with cardiovascular disease. In: Manual of psychiatric care for the medically ill. 1st ed. American Psychiatric Publishing, Inc. Washington 2004; 49-67.
90. Yan LL, Kiang L, Matthews KA, et al. Psychosocial factors and risk of hypertension: the coronary artery risk development in young adults (CARDIA) Study. JAMA 2003; 290: 2138-48.
91. Yeragani VK, Pohl R, Berger R, et al. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993; 46: 89-103.
92. Yeragani VK, Tancer M, Uhde T. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 2003; 121(2): 185-96.
93. Zvolensky MJ, Eifert GH, Feldner MT, et al. Heart-focused anxiety and chest pain in postangiography medical patients. J Behav Med 2003; 26(3): 197-209.
Review
For citations:
Starostina E.G. Anxiety and anxiety disorders in cardiology practice. Cardiovascular Therapy and Prevention. 2006;5(3):111-120. (In Russ.)
Views:
1224
Email this article 
